Profile

John Owen, M.D.Wake Forest Baptist Health

Doctor Rating

4.3 out of 5

37 Ratings
3 Comments
 

John Owen, M.D.

Professor,

Clinical Interests

Hematology and Blood Coagulation

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Insurance Accepted »

Education & Training

  • B.S.M., Mcmaster University Faculty Medicine-Canada, 1972
  • M.D., Mcmaster University Faculty Medicine-Canada, 1974
  • Fellowship, Thames Polytechnic - London, 1972
  • Residency, Internal Medicine, University Toronto Med-Canada, 1978
  • Fellowship, Columbia U Affil Hosps, 1979

Memberships

  • Aha - Thrombosis Council
  • Am Federation Of Clinical Rese
  • Am Gastrointestinal Endoscopy
  • Am Soc of Hematology
  • Fibrinogen Subcom.Int'Lthrombo
  • Harvey Society

NPI Number

  • 1366427411
John Owen, M.D.

Doctor Rating

4.3 out of 5

37 Ratings
3 Comments
 

John Owen, M.D.

Professor, Hematology & Oncology
Pathology

Contact Information

Academic: 336-716-5788 | Department: 336-716-4464

Recent Publications

Hemolytic anemia in two patients with glioblastoma multiforme: a possible interaction between vorinostat and dapsone. Lewis JA, Petty WJ, Harmon M, Peacock JE, Valente K, Owen J, Pirmohamed M, Lesser GJ.. J Oncol Pharm Pract. 2015;21(3):220-223.

Hypoxia and neoplasms: sickle cell patients as a living model [abstract]. Batt K, Isom S, Farland AM, Leedy D, Owen J, Bonomi MR.. J Clin Oncol. 2015;33(15 Suppl):e12591.

Hydroxyurea in sickle cell patients: a look at the correlation with hematologic malignancies [abstract]. Batt K, Isom S, Farland AM, Leedy D, Owen J, Bonomi MR.. J Clin Oncol. 2015;33(15 Suppl):e12593.

Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J.. Am J Hematol. 2014;89(7):695-697.

Amniotic fluid stem cells for the treatment of hemophilia A [abstract]. Kuo C-J, Mokhtari S, Soland M, Soker S, Yoo J, Owen J, Knovich MA, Atala A, Almeida-Porada G, Porada C.. Mol Ther. 2013;21(Suppl 1):S96-S97.

Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements. Knovich MA, Farland A, Owen J.. Eur J Haematol. 2012;88(6):518-525.

BsaXI/RFLP analysis of initial or selectively reamplified PCR product is unreliable in detecting the V617F mutation in JAK2. Shepard GC, Lawson HL, Hawkins GA, Owen J.. Int J Lab Hematol. 2011;33(3):267-271.

Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D'Agostino R Jr, Torti FM, Torti SV.. Biomaterials. 2011;32(26):5970-5978.

Myocardial necrosis in patients with thrombotic thrombocytopenic purpura: pathophysiology and rationale for specific therapy. Sane DC, Streer NP, Owen J.. Eur J Haematol. 2009;82(2):83-92.

Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Wilhelm AJ, Zabalawi M, Grayson JM, Weant AE, Major AS, Owen J, Bharadwaj M, Walzem R, Thomas MJ, Sorci-Thomas MG, et al.. Arterioscler Thromb Vasc Biol. 2009;29(6):843-849.

Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection. Wajih N, Owen J, Wallin R.. Thromb Res. 2008;122(3):405-410.

Rapid quantitative assay of ADAMTS13 activity on an automated coagulation analyzer: clinical applications and comparison with immunoblot method. Knovich MA, Lawson HL, Burke MH, McCoy TP, Owen J.. Am J Hematol. 2008;83(8):654-656.

Myocardial infarction in thrombotic thrombocytopenic purpura: a single-center experience and literature review. Wahla AS, Ruiz J, Noureddine N, Upadhya B, Sane DC, Owen J.. Eur J Haematol. 2008;81(4):311-316.

Link between ADAMTS-13 and troponin levels? [letter]. Sane DC, Owen J.. Crit Care Med. 2008;36(10):2959-2960.

ApoA-I FIN partially prevents cholesterol deposition and inflammation in skin and lymph nodes of diet-fed LDLr-/-, ApoA-I-/- mice [abstract]. Bharadwaj MS, Zabalawi M, Owen JS, Thomas MJ, Zannis VI, Duka A, Sorci-Thomas MG.. Arterioscler Thromb Vasc Biol. 2007;27(6):e-124.

Copper deficiency causes reversible myelodysplasia. Huff JD, Keung Y-K, Thakuri M, Beaty MW, Hurd DD, Owen J, Molnar I.. Am J Hematol. 2007;82(7):625-630.

Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays. Zhang L, Lawson HL, Harish VC, Huff JD, Knovich MA, Owen J.. Anal Biochem. 2006;358(2):298-300.

Isolated antiplasmin deficiency presenting as a spontaneous bleeding disorder in a 63-year-old man. Harish VC, Zhang L, Huff JD, Lawson H, Owen J.. Blood Coagul Fibrinolysis. 2006;17(8):673-675.

A rapid sensitive assay for measuring ADAMTS13 activity in plasma utilizing a novel recombinant Alexa488-vWF86 (Q1599\P1611C) FRET substrate [abstract]. Guinto ER, Grafos N, Owen J, Lawson HL, Greenfield RS.. Blood. 2006;108(11 Pt 2):88b.

Enhanced synthesis of functional recombinant factors IX and VII by BHK cells engineered to overexpress VKORC1 combined with siRNA silencing of the gamma-carboxylation inhibitor calumenin [abstract]. Wallin R, Wajih N, Owen J.. Blood. 2006;108(11 Pt 1):485a.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Hematology & Oncology

Clinical Interests

Hematology and Blood Coagulation
John Owen, M.D.

John Owen, M.D.

Professor, Hematology & Oncology
Pathology

Doctor Rating

4.3 out of 5

John Owen, M.D.37 Ratings
3 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.4
CP efforts to include in decisions
4.4
CP explanations of prob/condition
4.4
CP spoke using clear language
4.5
Friendliness/courtesy of CP
4.5
Likelihood of recommending CP
4.4
Patients' confidence in CP
4.5
Time CP spent with patient
4.3
Wait time at clinic
3.7



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

4/28/2016

*Dr. John Owens is extremely knowledgeable and had treated me for severe anemia about 12 years ago. He understands the condition well and knows about the treatment routine prescribed.

2/9/2016

Good.

9/3/2015

Good doctor. Very informative about my situation.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.